Skip to main content

Table 1 Clinicopathological characteristics of patients in the entire and PSM cohorts

From: Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients

Variables

Entire cohort

P

PSM cohort

P

 

RADG

(n = 441)

LADG

(n = 723)

 

RADG

(n = 410)

LADG

(n = 410)

 

Age, years

59.9 ± 11.5

59.7 ± 11.4

0.826

59.8 ± 10.8

59.7 ± 11.0

0.839

Sex, n (%)

  

0.768

  

0.189

 Male

308 (69.8)

499 (69.0)

 

284 (69.3)

301 (73.4)

 

 Female

133 (30.2)

224 (31.0)

 

126 (30.7)

109 (26.7)

 

BMI, kg/m2

23.2 ± 3.2

23.1 ± 3.1

0.472

23.1 ± 3.1

23.1 ± 3.0

0.971

ASA score, n (%)

  

0.630

  

0.741

 1

211 (47.8)

325 (45.0)

 

203 (49.5)

198 (48.3)

 

 2

154 (34.9)

267 (36.9)

 

133 (32.4)

143 (34.9)

 

 3

76 (17.3)

131 (18.1)

 

74 (18.1)

69 (16.8)

 

Tumor size, cm

4.1 ± 2.1

4.3 ± 2.6

0.233

4.1 ± 2.1

4.2 ± 2.2

0.642

Previous abdominal surgery, n (%)

  

 < 0.001

  

0.544

 No

416 (94.3)

601 (83.1)

 

389 (94.9)

385 (94.0)

 

 Yes

25 (5.7)

122 (16.9)

 

21 (5.1)

25 (6.0)

 

Type of reconstruction, n (%)

  

 < 0.001

  

0.939

 B-I

142 (32.2)

370 (51.2)

 

134 (32.7)

138 (33.7)

 

 B-II

258 (58.5)

260 (36.0)

 

244 (59.5)

239 (58.3)

 

Roux-en-Y

41 (9.3)

93 (12.8)

 

32 (7.8)

33 (8.0)

 

Histology type, n (%)

  

0.019

  

0.806

Well/moderately

101 (22.9)

211 (29.2)

 

96 (23.4)

99 (24.1)

 

Poorly/undifferentiated

340 (77.1)

512 (70.8)

 

314 (76.6)

311 (75.9)

 

Pathologic T stage, n (%)

  

 < 0.001

  

0.879

 T2

193 (43.8)

177 (24.5)

 

172 (42.0)

165 (40.2)

 

 T3

138 (31.3)

245 (33.9)

 

132 (32.2)

137 (33.4)

 

 T4a

110 (24.9)

301 (41.6)

 

106 (25.8)

108 (26.4)

 

Pathologic N stage, n (%)

  

0.732

  

0.942

 N0

190 (43.1)

323 (44.7)

 

182 (44.4)

188 (45.9)

 

 N1

73 (16.6)

113 (15.6)

 

70 (17.1)

68 (16.6)

 

 N2

82 (18.6)

119 (16.5)

 

80 (19.5)

82 (20.0)

 

 N3

96 (21.7)

168 (23.2)

 

78 (19.0)

72 (17.5)

 

Pathologic TNM stage, n (%)

  

0.079

  

0.970

 IB

50 (11.3)

99 (14.0)

 

48 (11.7)

52 (12.7)

 

 IIA

36 (8.2)

76 (10.5)

 

34 (8.3)

38 (9.3)

 

 IIB

83 (18.8)

110 (15.1)

 

73 (17.8)

71 (17.3)

 

 IIIA

64 (14.5)

130 (17.9)

 

60 (14.6)

58 (14.1)

 

 IIIB

88 (20.0)

148 (20.4)

 

87 (21.2)

79 (19.3)

 

 IIIC

120 (27.2)

160 (22.1)

 

108 (26.4)

112 (27.3)

 
  1. RADG robotic-assisted distal gastrectomy, LADG laparoscopic-assisted distal gastrectomy, PSM propensity score matching, BMI body mass index, ASA American Society of Anesthesiologists, TNM tumor-node-metastasis